Cascades Reports Mixed Q1 2026 Results Amid Cost Pressures
Event summary
- Cascades Inc. reported Q1 2026 sales of $1.125 billion, down from $1.197 billion in Q4 2025 and $1.154 billion in Q1 2025.
- Operating income was $81 million, up from $76 million in Q4 2025 but down from $50 million in Q1 2025.
- Adjusted EBITDA (A) was $118 million, a decrease of $7 million from the same period last year.
- Net debt remained stable at $1.901 billion, with a net debt to EBITDA (A) ratio of 3.3x.
- The company generated $91 million in asset sale proceeds during the quarter, bringing total proceeds to $149 million for the 2025-2026 period.
The big picture
Cascades' Q1 2026 results reflect the challenges of a dynamic macro-economic environment, including weather-related disruptions, geopolitical developments, and heightened volatility in transportation and fuel costs. The company's strategic focus on profitability improvements and asset portfolio optimization aims to mitigate these headwinds and restore annual run rate adjusted EBITDA (A) to approximately $600 million in the second half of the year.
What we're watching
- Cost Management
- Whether Cascades can effectively implement cost reduction initiatives and logistics optimization to offset rising input costs.
- Pricing Strategy
- The impact of announced price increases in packaging and tissue segments on consumer spending and market demand.
- Asset Sales
- The pace at which Cascades can achieve its target of $230 million in proceeds from non-core asset sales by the end of Q3 2026.
Related topics